Action Pharma A/S is a biopharmaceutical company founded in 2000 and located in Denmark

Our main strategy is to bring drug candidates rapidly from pre-clinical development into clinical trials for subsequent partnering.

The goal is to bring one drug candidate into clinical development per year and currently two lead candidates are in clinical development.

We plan to seek partners for late clinical development and commercialisation of our drug candidates after successful development in phase I or II by partnering with major biotech and pharmaceutical companies. 

 

MEET US

May 2009
BIO International Convention
Atlanta

June 2009
ADA 69th scientific sessions
New Orleans

September 2009
EASD
Vienna

more events

LATEST NEWS

Feb. 12, 2009

Action Pharma’s CEO awarded the Novo Nordisk Prize 2009  

Read more